Pie Medical Imaging BV of Maastricht, the Netherlands, introduced a new version of its CAAS Quantitative Coronary Analysis for Research software (CAAS QCA-R), QCA for Research 2.0, at the American College of Cardiology meeting, March 6 - 9, in Orlando, Fla.
   
The new version improves the method to evaluate the effectiveness of drug eluting stents (DES) by allowing users to analyze the proximal, distal and stented segment very quickly, the company said. Additional improvements include optimized multiple subsegments analysis, expanded subsegmental data analysis, more overall results and floating license possibility.    
   
Pie Medical Imaging CAAS software offers automatic contour detection of the coronary arteries and analysis of its dimensions. After calibration and contour detection of the artery, the analysis results are presented instantly. In addition to computer defined obstruction analysis, CAAS QCA-R offers user reference analysis, subsegments analysis, brachytherapy analysis and fast drug eluting stents (DES) analysis.
   
Results can be saved in DICOM, MS-Access and/or MS-Excel file formats, Pie Medical Imaging said.